AdvaMed recommends ways to improve CDRHs voluntary medical device manufacturing and product quality program.
Federal Register notice: FDA announces the Web site location where it will post two lists of guidance documents that CDRH intends to publish in fiscal...
Federal Register notice: FDA makes available a guidance entitled Product Name Placement, Size, and Prominence in Promotional Labeling and Advertisemen...
FDA releases its latest batch of Warning Letters that includes Fagron Compounding Services, RC Outsourcing and Seindni Co.
CDERs Office of Testing and Research outlines research it is conducting to better understand 3D or additive manufacturings use in making drug products...
FDA approves an Intersect ENT PMA for the Sinuva (mometasone furoate) Sinus Implant, a new targeted approach to treating recurrent nasal polyp disease...
Federal Register notice: FDA seeks comments on an information collection extension for FDA Application for Participation in FDA Fellowship Programs (F...
FDA posts a final guidance on Product Name Placement, Size, and Prominence in Promotional Labeling and Advertisements for drugs.